← Back to Search

Group A for Parkinson's Disease

N/A
Waitlist Available
Research Sponsored by Sun Life Financial Movement Disorders Research and Rehabilitation Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 weeks and 24 weeks
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is 1.) to determine if sensory attention focused exercise is an effective management strategy for Parkinson's disease, and 2.) to identify if the benefits are a result of strength gains.

Eligible Conditions
  • Parkinson's Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 weeks and 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 weeks and 24 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Unified Parkinson's Disease Rating Scale (UPDRS) III (motor score)
Secondary study objectives
30 second chair stand
Grooved Pegboard
Step Length
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group BExperimental Treatment1 Intervention
Participants received no treatment for 12 weeks, then received Sensory Attention Focused Exercise for 12 weeks.
Group II: Group AExperimental Treatment1 Intervention
Participants received 12 weeks of Sensory Attention Focused Exercise, then received 12 weeks of no exercise.

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,386 Previous Clinical Trials
26,515,899 Total Patients Enrolled
Canada, Young Men's Christian Association (YMCA)UNKNOWN
Parkinson Society CanadaOTHER
3 Previous Clinical Trials
79 Total Patients Enrolled
~4 spots leftby Nov 2025